Saturday 24 January 2015

FDA approves NPS drug, in move validating Shire takeover deal

(Reuters) - The U.S. Food and Drug Administration has approved NPS Pharmaceuticals Inc.'s drug Natpara to treat a rare hormone disorder, validating a bet by Shire Plc, which recently agreed to acquire NPS for $5.2 billion.


via Reuters: Health News Read More Here..

No comments:

Post a Comment